Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The objective of this Funding Opportunity Announcement (FOA) is to pair Bioengineers and Immunologists to leverage emerging innovative knowledge in physical and computational sciences for the design and development of an HIV-1 vaccine.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • AIDS Application Due Date(s): July, 28, 2020

​RFA-AI-20-015 Expiration Date July 29, 2020

Eligibility

Faculty

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Interdisciplinary
Medical
Medical - Clinical Science
Medical - Translational

External Deadline

July 28, 2020